Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PRECISIONscientia is a healthcare-focused medical communications agency that supports pharmaceutical and biotechnology companies with scientific and medical communications across the product lifecycle. The business specializes in translating complex clinical and scientific data into content and strategy for medical affairs, marketing, launch planning, congress activities, field training, and key opinion leader engagement. Founded in 2002 and formerly known as ETHOS Health Communications, the company became part of the broader Precision Value & Health organization and has since been integrated into Precision Medicine Group’s commercialization capabilities. PRECISIONscientia is not a drug developer with an internal therapeutic pipeline; rather, it provides outsourced expertise to life sciences clients developing and commercializing therapies across many disease areas. The brand has also been associated with the broader Precision AQ commercialization platform following the 2024 rebranding of Precision Value & Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PRECISIONscientia.